WHO Multicenter Evaluation of FACSCount CD4 and Pima CD4 T-Cell Count Systems: Instrument Performance and Misclassification of HIV-Infected Patients

Background:CD4+ T-cell counts are used to screen and follow-up HIV-infected patients during treatment. As part of the World Health Organization prequalification program of diagnostics, we conducted an independent multicenter evaluation of the FACSCount CD4 and the Pima CD4, using the FACSCalibur as reference method. Methods:A total of 440 paired capillary and venous blood samples were collected from HIV-infected patients attending the HIV outpatient clinic in Antwerp, Belgium, and the HIV care and treatment center in Dar es Salam, Tanzania. Capillary blood was run on Pima analyzer, whereas venous blood was analyzed on FACSCount, Pima, and FACSCalibur instruments. Precision and agreement between methods were assessed. Results:The FACSCount CD4 results were in agreement with the FACSCalibur results with relative bias of 0.4% and 3.1% on absolute CD4 counts and an absolute bias of −0.6% and −1.1% on CD4% in Antwerp and Dar es Salam, respectively. The Pima CD4 results were in agreement with the FACSCalibur results with relative bias of −4.1% and −9.4% using venous blood and of −9.5% and −0.9% using capillary blood in Antwerp and Dar es Salam, respectively. At the threshold of 350 cells per microliter, the FACSCount CD4 and Pima CD4 using venous and capillary blood misclassified 7%, 9%, and 13% of patients, respectively. Conclusions:The FACSCount CD4 provides reliable CD4 counts and CD4% and is suitable for monitoring adult and pediatric HIV patients in moderate-volume settings. The Pima CD4 is more suitable for screening eligible adult HIV patients for antiretroviral treatment initiation in low-volume laboratories.

[1]  R. Paranjape,et al.  A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians , 2010, The Indian journal of medical research.

[2]  S. Solomon,et al.  Comparison of Microcapillary Cytometry Technology and Flow Cytometry for CD4+ and CD8+ T-Cell Estimation , 2005, Clinical Diagnostic Laboratory Immunology.

[3]  Luc Kestens,et al.  Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents. , 2011, Journal of immunological methods.

[4]  Ronald H Gray,et al.  HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy , 2011, AIDS.

[5]  T. Peter,et al.  Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing , 2011, AIDS.

[6]  Michael J Lochhead,et al.  Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. , 2013, Journal of immunological methods.

[7]  M A Pollock,et al.  Method Comparison—A Different Approach , 1992, Annals of clinical biochemistry.

[8]  P M Broughton,et al.  A Revised Scheme for the Evaluation of Automatic Instruments for Use in Clinical Chemistry , 1974, Annals of clinical biochemistry.

[9]  T. Flanigan,et al.  A Reliable and Inexpensive EasyCD4 Assay for Monitoring HIV-Infected Individuals in Resource-Limited Settings , 2006, Journal of acquired immune deficiency syndromes.

[10]  C. Rowley.  Developments in CD4 and viral load monitoring in resource-limited settings. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Deborah K Glencross,et al.  Multiple method comparison: Statistical model using percentage similarity , 2003, Cytometry. Part B, Clinical cytometry.

[12]  Julian Gold,et al.  Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. , 2007 .

[13]  Douglas Chesher,et al.  Evaluating assay precision. , 2008, The Clinical biochemist. Reviews.

[14]  K. Pattanapanyasat,et al.  Comparison of 5 Flow Cytometric Immunophenotyping Systems for Absolute CD4+ T-Lymphocyte Counts in HIV-1-Infected Patients Living in Resource-Limited Settings , 2008, Journal of acquired immune deficiency syndromes.

[15]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[16]  H. P. Study.  Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children , 2006, AIDS.

[17]  R. Paranjape,et al.  Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India , 2012, AIDS Research and Therapy.

[18]  F. Mbopi-Kéou,et al.  Validation of a Single-Platform, Volumetric, CD45-Assisted PanLeucogating Auto40 Flow Cytometer To Determine the Absolute Number and Percentages of CD4 T Cells in Resource-Constrained Settings Using Cameroonian Patients' Samples , 2012, Clinical and Vaccine Immunology.

[19]  Andrew Copas,et al.  Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service , 2012, Sexually Transmitted Infections.

[20]  McDougal Js,et al.  Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[21]  S. Mboup,et al.  CD4 T-Cell Enumeration in a Field Setting: Evaluation of CyFlow Counter Using the CD4 Easy Count Kit-Dry and Pima CD4 Systems , 2013, PloS one.

[22]  J. Greve,et al.  Clinical evaluation of a simple image cytometer for CD4 enumeration on HIV‐infected patients , 2009, Cytometry. Part B, Clinical cytometry.

[23]  Luc Kestens,et al.  Absolute CD4 T-Cell Counting in Resource-Poor Settings: Direct Volumetric Measurements Versus Bead-Based Clinical Flow Cytometry Instruments , 2005, Journal of acquired immune deficiency syndromes.

[24]  G Janossy,et al.  Affordable CD4 T‐cell enumeration for resource‐limited regions: A status report for 2008 , 2008, Cytometry. Part B, Clinical cytometry.

[25]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[26]  L. Myer,et al.  Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women , 2013, Journal of the International AIDS Society.

[27]  Yves Traoré,et al.  Simplified Volumetric Flow Cytometry Allows Feasible and Accurate Determination of Cd4 T Lymphocytes in Immunodeficient Patients Worldwide , 2003, Antiviral therapy.

[28]  F. Mandy,et al.  Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  A Orfao,et al.  Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. , 1996, Cytometry.

[30]  G. Mazurek,et al.  Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus; Guidelines for using the quantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection , 2003 .

[31]  Deborah K Glencross,et al.  A North American multilaboratory study of CD4 counts using flow cytometric panleukogating (PLG): A NIAID‐DAIDS Immunology Quality Assessment Program Study , 2008, Cytometry. Part B, Clinical cytometry.

[32]  M. O'gorman,et al.  Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive Adults , 2000, Clinical Diagnostic Laboratory Immunology.

[33]  Trevor Peter,et al.  Evaluation of the PIMA Point-of-Care CD4 Analyzer in VCT Clinics in Zimbabwe , 2010, Journal of acquired immune deficiency syndromes.

[34]  John T McDevitt,et al.  A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings , 2005, PLoS medicine.

[35]  M. Holstad,et al.  Adherence, sexual risk, and viral load in HIV-infected women prescribed antiretroviral therapy. , 2011, AIDS patient care and STDs.

[36]  R Zachariah,et al.  The Partec CyFlow Counter could provide an option for CD4+ T-cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  L. Lynen,et al.  Validation of Primary CD4 Gating as an Affordable Strategy for Absolute CD4 Counting in Cambodia , 2006, Journal of acquired immune deficiency syndromes.

[38]  B. Castelnuovo,et al.  Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy , 2012, PloS one.

[39]  W. Bablok,et al.  A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[40]  K. Pattanapanyasat,et al.  Performance Evaluation of the Alere PIMA CD4 Test for Monitoring HIV-Infected Individuals in Resource-Constrained Settings , 2011, Journal of acquired immune deficiency syndromes.

[41]  T. R. D. de Wit,et al.  Timing of blood sampling for CD4 T-cell counting influences HAART decisions. , 2011, Ethiopian medical journal.

[42]  M. O'gorman,et al.  CD4 T cell measurements in the management of antiretroviral therapy—A review with an emphasis on pediatric HIV‐infected patients , 2008, Cytometry. Part B, Clinical cytometry.

[43]  K. Pattanapanyasat,et al.  New BD FACSCount™ CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T‐lymphocytes in HIV‐1‐infected pediatric patients , 2008, Cytometry. Part B, Clinical cytometry.

[44]  W. Stevens,et al.  Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa , 2012, Journal of the International AIDS Society.

[45]  S. Mboup,et al.  Multisite Evaluation of a Point-of-Care Instrument for CD4+ T-Cell Enumeration Using Venous and Finger-Prick Blood: The PIMA CD4 , 2011, Journal of acquired immune deficiency syndromes.

[46]  Mehmet Toner,et al.  A Microchip Approach for Practical Label-Free CD4+ T-Cell Counting of HIV-Infected Subjects in Resource-Poor Settings , 2007, Journal of acquired immune deficiency syndromes.

[47]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[48]  M. Mwau,et al.  Evaluation of PIMA™® Point of Care Technology for CD4 T Cell Enumeration in Kenya , 2013, PloS one.

[49]  C. Masimirembwa,et al.  Evaluation of the Partec Flow Cytometer against the BD FACSCalibur System for Monitoring Immune Responses of Human Immunodeficiency Virus-Infected Patients in Zimbabwe , 2007, Clinical and Vaccine Immunology.